DrugPatentWatch provides comprehensive details on FDA approved drugs, developers and patents. The integrated databases allow both freeform searching and dynamic browsing, making it easy to find information on drug patents both in the US and internationally, sales figures, trends in patent expirations and top patent holders.
DrugPatentWatch incorporates many data sources. Each is updated as frequently as possible, providing you with fresh information.
The core data are updated monthly, using feeds directly from the FDA and USPTO. Sales information is updated annually. The accessory data, such as tentative approvals, US patent details, internaional patent information, etc., are updated weekly. Clinical trial and Paragraph IV data are updated daily.
Annual editions — available in the Premium and Ultimate plans — provide historic archives of the state of drug patent expirations in each recorded year.
BiologicPatentWatch contains information on FDA-approved small molecule drugs.
For information on biologics, see BiologicPatentWatch.com
Do you have needs beyond DrugPatentWatch's current offerings? Please let us know at admin@DrugPatentWatch.com
DrugPatentWatch is a product of thinkBiotech LLC, and is managed by Yali Friedman, Ph.D.
Dr. Friedman is also publisher and chief editor of the Journal of Commercial Biotechnology. His first book, Building Biotechnology, is used as a course text in dozens of biotechnology programs. His other books include Best Practices in Biotechnology Education and Best Practices in Biotechnology Business Development. He is also a member of the board of directors of AmericasHealth, serves on the science advisory board of Chakra Biotech, is an associate member of the World Technology Network, and also serves as a judge for the Biotech Humanitarian Award and the Maryland Incubator Company of the Year Award.
Dr. Friedman has strong exposure to leading issues in international biotechnology. He is lead editorial consultant for Scientific American's worldVIEW, a global biotechnology perspective profiling biotechnology industries and innovation capacity in dozens of countries, and has been invited to participate in biotechnology industry development forums for international groups such as APEC and for individual countries such as Japan, Canada, Germany, the Philippines, and Turkey.
Dr. Friedman teaches biotechnology management at the National Institutes of Health and regularly guest-lectures for other biotechnology education programs. He writes and speaks on diverse topics such as biotechnology entrepreneurship, strategies to cope with a lack of management talent and capital when developing companies outside of established hubs, and new paradigms in technology-based economic development.
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639`abc